Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer.

Fabian HauptGeorg BerdingAli NamazianFlorian WilkeAlena BökerAxel MerseburgerLilli GeworskiMarkus Antonius KuczykFrank Michael BengelInga Peters

Published in: Advances in therapy (2017)

Distinct thresholds of the relative aBSI could help to better assess disease progression in mPCa patients. Manual corrections of the BSI values are not required in most cases. The aBSI could serve as a useful additional parameter for therapy monitoring in mPCa patients in the future.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
small cell lung cancer
peritoneal dialysis
prognostic factors
bone mineral density
mesenchymal stem cells
patient reported outcomes
radical prostatectomy
cell therapy